Charles E Dean
The Skeptical Professional's Guide to Psychiatry
On the Risks and Benefits of Antipsychotics, Antidepressants, Psychiatric Diagnoses, and Neuromania
Charles E Dean
The Skeptical Professional's Guide to Psychiatry
On the Risks and Benefits of Antipsychotics, Antidepressants, Psychiatric Diagnoses, and Neuromania
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This text critically examines the shortcomings of psychiatry, the flawed development of the diagnostic system, including the DSM-5, and the failure to advance the effectiveness of antipsychotics and antidepressants.
Andere Kunden interessierten sich auch für
- Joel ParisThe Bipolar Spectrum192,99 €
- Martin FleishmanThe Casebook of a Residential Care Psychiatrist159,99 €
- Alan J. Gelenberg / Ellen L. Bassuk (Hgg.)The Practitioner's Guide to Psychoactive Drugs124,99 €
- Dean F. MacKinnonStill Down49,99 €
- Ben Vitiello / Gabriele Masi / Donatella Marazziti (eds.)Handbook of Child and Adolescent Psychopharmacology163,99 €
- Edward H DrummondThe Complete Guide to Psychiatric Drugs17,99 €
- Animal and Translational Models for CNS Drug Discovery: Neurological Disorders112,99 €
-
-
-
This text critically examines the shortcomings of psychiatry, the flawed development of the diagnostic system, including the DSM-5, and the failure to advance the effectiveness of antipsychotics and antidepressants.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 338
- Erscheinungstermin: 23. November 2020
- Englisch
- Abmessung: 231mm x 155mm x 23mm
- Gewicht: 590g
- ISBN-13: 9780367469313
- ISBN-10: 0367469316
- Artikelnr.: 60011513
- Verlag: Taylor & Francis
- Seitenzahl: 338
- Erscheinungstermin: 23. November 2020
- Englisch
- Abmessung: 231mm x 155mm x 23mm
- Gewicht: 590g
- ISBN-13: 9780367469313
- ISBN-10: 0367469316
- Artikelnr.: 60011513
Charles E. Dean, M.D., has 47 years of clinical, educational, and research experience. He has taught psychopharmacology and clinical neuroscience at the Minneapolis VA Medical Center and the University of Minnesota.
List of Abbreviations; Permissions; Introduction; Chapter 1. The Biological
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
List of Abbreviations; Permissions; Introduction; Chapter 1. The Biological
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.